IP Library Granted Patent US 8,702,586
Granted Patent B2
US 8,702,586 · App. 13/252,324 · Granted Apr 22, 2014

Implantable article and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,702,586
App. No.
13/252,324
Granted
Apr 22, 2014
Kind
B2
Abstract

An implantable article and method are disclosed for treating pelvic floor disorders such as vaginal vault prolapse. A surgical kit useful for performing a surgical procedure such as a sacral colpopexy is also described.

Claims (27)

1. A method of treating a pelvic floor disorder with a sacrocolpopexy procedure, comprising:

providing an implant having an anterior vaginal mesh portion, a posterior vaginal mesh portion and a sacral mesh extension portion;

creating an incision;

attaching the anterior vaginal mesh portion to the anterior vaginal wall;

attaching the posterior vaginal mesh portion to the posterior vaginal wall;

attaching the sacral mesh extension portion to sacral fascia; and

adjusting the tension of the implant.

2. The method of claim 1 , wherein attaching the mesh extension portion to the sacral fascia includes attaching the mesh extension portion to the anterior longitudinal ligament.

3. The method of claim 1 , wherein attaching the mesh extension portion to the sacral fascia includes attaching the mesh extension portion to sacral soft tissue.

4. The method of claim 1 , wherein creating an incision includes creating an abdominal incision.

5. The method of claim 1 , wherein creating an incision includes creating a vaginal incision.

6. The method of claim 1 , wherein attaching the anterior vaginal mesh portion to the anterior vaginal wall includes attachment with one or more sutures.

7. The method of claim 1 , wherein attaching the posterior vaginal mesh portion to the posterior vaginal wall includes attachment with one or more sutures.

8. The method of claim 1 , wherein the anterior vaginal mesh portion is a substantially flat mesh portion.

9. The method of claim 1 , wherein the posterior vaginal mesh portion is a substantially flat mesh portion.

10. A method of treating a pelvic floor disorder with a sacrocolpopexy procedure, comprising:

providing an implant having an anterior vaginal mesh portion, a posterior vaginal mesh portion and a sacral mesh extension portion;

creating an incision;

suturing the anterior vaginal mesh portion to the anterior vaginal wall;

suturing the posterior vaginal mesh portion to the posterior vaginal wall;

affixing the sacral mesh extension portion to the longitudinal ligament of the sacral fascia; and

tensioning the implant.

11. The method of claim 10 , wherein affixing the mesh extension portion to the longitudinal ligament of the sacral fascia includes affixing the mesh extension portion to the anterior longitudinal ligament of the sacral fascia.

12. The method of claim 10 , wherein creating an incision includes creating an abdominal incision.

13. The method of claim 10 , wherein creating an incision includes creating a vaginal incision.

14. The method of claim 10 , wherein the anterior vaginal mesh portion is a substantially flat mesh portion.

15. The method of claim 10 , wherein the posterior vaginal mesh portion is a substantially flat mesh portion.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2011
From: AMERICAN MEDICAL SYSTEMS, INC.
To: AMS RESEARCH CORPORATION
Reel/Frame 027010/0679 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2011
From: THIERFELDER, CHRISTOPHER A.; WESTRUM, JOHN W., JR.
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 027010/0647 →